The importance of clarithromycin dose in the management of H-pylori infection:: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole -: Reply

被引:0
|
作者
Huang, JQ [1 ]
Hunt, RH [1 ]
机构
[1] McMaster Univ, Med Ctr, Hamilton, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1693 / 1694
页数:2
相关论文
共 50 条
  • [41] Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication:: a meta-analysis
    Vallve, M
    Vergara, M
    Gisbert, JP
    Calvet, X
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1149 - 1156
  • [42] Evaluation of Two Triple-Therapy Regimens with Metronidazole or Clarithromycin for the Eradication of H-pylori Infection in Vietnamese Children: a Randomized, Double-Blind Clinical Trial
    Nguyen, Thi Viet Ha
    Bengtsson, Carina
    Nguyen, Gia Khanh
    Hoang, Thi Thu Ha
    Phung, Dac Cam
    Sorberg, Mikael
    Granstrom, Marta
    HELICOBACTER, 2008, 13 (06) : 550 - 556
  • [43] Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis
    Murata, Masaki
    Sugimoto, Mitsushige
    Mizuno, Hitomi
    Kanno, Takeshi
    Satoh, Kiichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [44] Seven-day versus 10-to 14-day therapies with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection.: A metaanalysis.
    Calvet, X
    Garcia, N
    Lopez, T
    Gisbert, JP
    Gene, E
    Tauli, CP
    GASTROENTEROLOGY, 2000, 118 (04) : A494 - A494
  • [45] Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection
    Venerito, Marino
    Krieger, Tina
    Ecker, Thomas
    Leandro, Gioacchino
    Malfertheiner, Peter
    DIGESTION, 2013, 88 (01) : 33 - 45
  • [46] Metronidazole (MNZ) is more effective than amoxicillin (AMOX) in combination with clarithromycin (CAM) and proton pump inhibitor (PPI) for Helicobacter pylori (H. pylori) eradication in Japan.
    Suga, M
    Takada, H
    Kanozawa, S
    Koizumi, K
    Takahashi, M
    Kuwayama, H
    GASTROENTEROLOGY, 2002, 122 (04) : A587 - A588
  • [47] Rabeprazol versus "Old" generation proton pump inhibitors (PPIs) for the eradication of H-pylori:: A meta-analysis
    McNicholl, A. G.
    Linares, P. M.
    Calvet, X.
    Gisbert, J. P.
    HELICOBACTER, 2008, 13 (05) : 461 - 462
  • [48] Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis
    Ang, Tiing Leong
    Wang, Luokai
    Ang, Daphne
    Chiam, Priscilla
    Fock, Kwong Ming
    Teo, Eng Kiong
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (02) : 100 - 104
  • [49] An updated meta-analysis of different duration of first-line, clarithromycin-based triple therapy for Helicobacter pylori infection
    Fuccio, L.
    Minardi, M. E.
    Zagari, R. M.
    Bazzoli, F.
    HELICOBACTER, 2006, 11 (04) : 386 - 386
  • [50] Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin
    Furuta, T
    Shirai, N
    Takashima, M
    Xiao, F
    Hanai, H
    Sugimura, H
    Ohashi, K
    Ishizaki, T
    Kaneko, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 158 - 168